P8A:SGX
Cordlife Group Ltd
၀.၁၂ SGD
၀.၀၀%
(၀.၀၀) 1D
အောက် ၁၂, GMT+၈ ၀၉:၄၉:၂၀ · SGD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for P8A...
Mkt. cap
၃.၂၄ ကုဋေ
Avg. vol.
၁.၂၂ ထောင်
Volume
၀.၀၀
52-wk high
၀.၂၆ SGD
52-wk low
၀.၁၀ SGD
EPS
-၀.၀၄ SGD
Shares outstanding
၂၆.၇၅ ကုဋေ
No. of employees
၁၁၁
Mkt. cap
၃.၂၄ ကုဋေ
Avg. vol.
၁.၂၂ ထောင်
Volume
၀.၀၀
52-wk high
၀.၂၆ SGD
52-wk low
၀.၁၀ SGD
EPS
-၀.၀၄ SGD
Shares outstanding
၂၆.၇၅ ကုဋေ
No. of employees
၁၁၁
News stories
From web sources and news partners
Finviz
·
ပြီးခဲ့သည့် ၁ နာရီ
OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight
The Fintech Times
·
ပြီးခဲ့သည့် ၁၇ မိနစ်
First Digital to List on Nasdaq via SPAC Deal at $250m Valuation
Yahoo Finance
·
ပြီးခဲ့သည့် ၁ နာရီ
Anthropic IPO Buzz Has Investors Watching Nasdaq Stock And ECM Fee Winners
Bloomberg.com
·
ပြီးခဲ့သည့် ၄ နာရီ
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Profile
Cordlife Group Limited, is a consumer health company incorporated in May 2001 and a provider of cord blood and cord lining banking services in Asia. Cordlife has been listed on the mainboard of SGX since March 2012.
Cordlife Group owns the largest network of cord blood banks in Asia with full stem cell processing and storage facilities in six markets including Singapore, Hong Kong, India, Indonesia, and the Philippines. Beyond cord blood and cord lining banking, Cordlife offers diagnostics services, particularly for the mother and child segment, including urine-based newborn metabolic screening, non-invasive prenatal testing, paediatric vision screening and family genetic screening services.
Cordlife's stem cell processing and storage facilities in Singapore, Hong Kong, India, Indonesia, the Philippines and Malaysia were accredited by AABB until 2024 when its accreditation was withdrawn.
In November 2023, the Ministry of Health of Singapore revealed that Cordlife Group had exposed cryopreserved cord blood units at suboptimal temperatures, damaging the cord blood units belonging to at least 2,150 clients and rendering them unsuitable for stem cell transplant purposes. Wikipedia
About Cordlife Group Ltd
CEOYiu Pang Fai
Employees၁၁၁
Founded၂၀၀၁ မေ ၂
Headquarters-
SectorHealth care provider
Websitecordlife.com